Skip to main content
AmigoFish

KarXT: A New Era in Antipsychotics?

From Psychopharmacology and Psychiatry Updates · · 12 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

In this episode, we explore KarXT, a newly FDA-approved antipsychotic with a groundbreaking cholinergic mechanism, through the lens of a single powerful metric: the Number Needed to Treat. Could an NNT of 5 change how you approach treatment-resistant schizophrenia?

Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.

- Learn more about our membership here

- Earn 0.75 CMEs: Quick Take Vol. 80

- How Effective Is KarXT (Xanomeline-Trospium) for Schizophrenia? NNT and NNH Explained

Back to Psychopharmacology and Psychiatry Updates · Report a problem